2015. Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis. Archivio Italiano di Urologia e Andrologia. 87, 2 (Jul. 2015), 121–129. DOI:https://doi.org/10.4081/aiua.2015.2.121.